Thought 5-Amino-1MQ was hype, it's actually doing something

R
Joined 2026
37 posts
3/19/2026 · 744 views

Contrarian update. I dismissed 5-Amino-1MQ as another NNMT-inhibitor hype compound for a year. Finally tried it on a friend's insistence.

12 weeks, 100mg oral daily. Maintenance calories. No other changes.

-1.1kg scale weight. DEXA says -0.9kg fat, +0.1kg LBM. Not dramatic, but at maintenance calories with nothing else moved? That's something.

Not changing my mind that the long-term safety data is thin. But I'm updating from "nothing" to "real but uncertain."

5 Replies

M
Joined 2026
32 posts
motsc_opsMember
29d ago

This matches my stack experience. 5A1MQ is doing something distinct from MOTS-c on body comp.

S
Joined 2026
115 posts
28d ago

The mechanism (NNMT inhibition → methyl donor availability → sirtuin activity) is plausible. The long-term safety of chronic NNMT inhibition in humans is the open question. I wouldn't run it continuously.

H
Joined 2025
205 posts
hexaclinicContributor
26d ago

Aggressive cycling (12 on, 12 off) is the conservative play here until there's more data. Don't run it year-round.

Q2 stack
  • CJC-1295 no DAC · 100 mcg · pre-bed · sub-Q
  • Ipamorelin · 200 mcg · pre-bed · sub-Q
  • BPC-157 · 500 mcg · 2x/day · sub-Q
R
Joined 2026
37 posts
24d ago

That's my plan. Off for 12 now, will rerun once if body comp holds.

F
Joined 2026
30 posts
20d ago

At maintenance calories with -0.9kg DEXA fat over 12 weeks — that is meaningful for a non-pharma agent. Would be curious to see this in someone losing on a deficit as well.

Sign in to reply.